MedPath

Dexmedetomidine

Generic Name
Dexmedetomidine
Brand Names
Dexdor, Igalmi, Precedex, Dexmedetomidine Accord
Drug Type
Small Molecule
Chemical Formula
C13H16N2
CAS Number
113775-47-6
Unique Ingredient Identifier
67VB76HONO

Overview

An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.

Background

An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.

Indication

Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.

Associated Conditions

  • Agitation
  • Alcohol Withdrawal Syndrome

FDA Approved Products

Dexmedetomidine
Manufacturer:Akorn
Route:INTRAVENOUS
Strength:100 ug in 1 mL
Approved: 2014/11/25
NDC:17478-055
Dexmedetomidine Hydrochloride
Manufacturer:WG Critical Care, LLC
Route:INTRAVENOUS
Strength:100 ug in 1 mL
Approved: 2021/12/31
NDC:44567-601
Dexmedetomidine
Manufacturer:Mylan Institutional LLC
Route:INTRAVENOUS
Strength:100 ug in 1 mL
Approved: 2020/03/16
NDC:67457-251
Dexmedetomidine hydrochloride
Manufacturer:Medical Purchasing Solutions, LLC
Route:INTRAVENOUS
Strength:100 ug in 1 mL
Approved: 2023/06/01
NDC:71872-7030
Dexmedetomidine Hydrochloride
Manufacturer:Fresenius Kabi USA, LLC
Route:INTRAVENOUS
Strength:100 ug in 1 mL
Approved: 2020/11/30
NDC:63323-421

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath